Structured desmopressin withdrawal improves response and treatment outcome for monosymptomatic enuretic children

Journal of Urology

Volumn 182, Issue 4 SUPPL., 2009, Pages 2022-2027

  Marschall Kehrel, Daniela ^a   Harms, Thomas W ^a  

^a Urology Consultancy   (Germany)

Author keywords

Deamino arginine vasopressin; Dose response relationship, drug; Enuresis; Recurrence; Urinary bladder

Indexed keywords

ANTIDIURETIC AGENT; ARGIPRESSIN[1 DEAMINO];

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL PROTOCOL; CLINICAL TRIAL; FEMALE; HUMAN; MALE; MULTICENTER STUDY; NOCTURNAL ENURESIS; PRESCHOOL CHILD; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTIDIURETIC AGENTS; CHILD; CHILD, PRESCHOOL; CLINICAL PROTOCOLS; DEAMINO ARGININE VASOPRESSIN; FEMALE; HUMANS; MALE; NOCTURNAL ENURESIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 70350499180     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2009.03.068     Document Type: Conference Paper

References (20)

1. Nijman R, Bower W, Butler U et al: Diagnosis and management of urinary incontinence and encopresis in childhood. In: Incontinence. Edited by P Abrams, L Cardozo, S Khoury et al. Plymouth, United Kingdom: Health Publication Limited 2005; vol 2, pp 965-1058.
2. Butler R, Heron J and the ALSPAC Study Team: Exploring the differences between mono- and polysymptomatic nocturnal enuresis. Scand J Urol Nephrol 2006; 404: 313.
3. Limbach A, Hückel D, Gelbrich G et al: Modulation of arousal reaction in children with nocturnal enuresis. Klin Paediatr 2007; 219: 230.
4. Eggert P, Fritz A, Stecker B et al: Desmopressin has an influence on the arousability of children with primary nocturnal enuresis. J Urol 2004; 171: 2586.
5. Riccabona M, Oswald J and Glauninger P: Longterm use and tapered dose reduction of transnasal desmopressin in the treatment of enuretic child. BJU Int, suppl., 1998; 81: 24.
6. Snajderova M, Lehotska V, Kernova T et al: Desmopressin in a long-term treatment of children with primary nocturnal enuresis - a symptomatic therapy? Eur J Pediatr 2001; 160: 197.
7. Butler RJ, Holland P and Robinson J: Examination of the structured withdrawal program to prevent relapse of nocturnal enuresis. J Urol 2001; 166: 2463.
8. Neveus T, Läckgren G, Tuvemo T et al: Enuresis - background and treatment. Scand J Urol Nephrol, suppl., 2000; 206: 1.
9. Kruse S, Hellström AL and Hjalmas K: Daytime bladder dysfunction in therapy-resistant nocturnal enuresis. Scand J Urol Nephrol 1999; 33: 49.
10. Neveus T, von Gontard A, Hoebeke P et al: The standardization of terminology of lower urinary tract function in children and adolescents; report from the Standardisation Committee of the International Children's Continence Society. J Urol 2006; 176: 314.
11. Van Hoeck KJ, Bael A, Van Dessel E et al: Do holding exercises or antimuscarinics increase maximum voided volume in monosymptomatic nocturnal enuresis? A randomized controlled trial in children. J Urol 2007; 178: 2132.
12. Allen HA, Austin CJ, Boyt MA et al: Initial trial of timed voiding is warranted for all children with daytime incontinence. Urology 2007; 69: 962.
13. Glazener CMA, Evans JHC and Peto RE: Alarm interventions for nocturnal enuresis in children. Cochrane Database Syst Rev 2005; 2: CD002911.
14. Butler R and Stenberg A: Review - treatment of childhood nocturnal enuresis: an examination of clinically relevant principles. BJU Int 2001; 88: 563.
15. Evans J and Lottmann H: Desmopressin response in the treatment of primary nocturnal enuresis in the U. K.: an open label, randomised comparative study comparing oral desmopressin versus alarm ICS 2007. Presented at annual meeting of International Continence Society, Rotterdam, The Netherlands, August 24, 2007, poster 225.
16. Wolfish NM: Sleep/arousal and enuresis subtypes. J Urol 2001; 166: 2444.
17. Kamperis K, Rittig S, Jorgensen KA et al: Nocturnal polyuria in monosymptomatic nocturnal enuresis refractory to desmopressin treatment. Am J Phys Ren Phys 2006; 291: 1232.
18. Yeung CK, Sit FK, To LKC et al: Reduction in nocturnal functional bladder capacity is a common factor in pathogenesis of refractory enuresis. BJU Int 2002; 160: 302.
19. Baeyens D, Roeyers H, Hoebeke P et al: The impact of attention deficit hyperactivity disorders on brainstem dysfunction in nocturnal enuresis. J Urol 2006; 176: 744.
20. Robben JH, Sze M, Knoers NV et al: Relief of nocturnal enuresis by desmopressin is kidney and vasopressin type 2 receptor independent. J Am Soc Nephrol 2007; 18: 1534.